[S. Baumgartner and J. Kristl, Optimisation of floating matrix tablets and evaluation of their gastric residence time, Int. J. Pharm. 195 (2000) 125-135; DOI: 10.1016/S0378-5173(02)00022-4.10.1016/S0378-5173(02)00022-4]Search in Google Scholar
[A. Streubel, J. Siepmann and R. Bodmeier, Floating matrix tablets based on low-density foam powder: effects of formulation and processing parameters on drug release, Eur. J. Pharm. Sci. 18 (2003) 37-45; DOI: 10.1016/S0928-0987(02)00223-3.10.1016/S0928-0987(02)00223-3]Search in Google Scholar
[J. K. Patel and J. R. Chavda, Formulation and evaluation of stomach specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy, J. Microencap. 26 (2009) 305-376; DOI: 10.1080/02652040802373012.10.1080/02652040802373012]Search in Google Scholar
[H. R. Chueh, H. Zia and C. T. Rhodes, Optimization of sotalol and bioadhesive extended-release tablet formulations, Drug Dev. Ind. Pharm. 21 (1995) 1725-1747; DOI: 10.3109/03639049102946315.]Search in Google Scholar
[B. N. Singh and K. H. Kim, Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention, J. Control. Release 63 (2000) 235-259; DOI: 10.1016/S0168-3659(99)00204-7.10.1016/S0168-3659(99)00204-7]Search in Google Scholar
[W. A. Ritschel, Targeting in the gastrointestinal tract: New approaches, Methods Find. Exp. Clin. Pharmacol. 13 (1991) 313-316.]Search in Google Scholar
[S. Li, S. Lin and B. P. Daggy, Effect of formulation variables on the floating properties of gastric floating drug delivery system, Drug Dev. Ind. Pharm. 28 (2002) 783-793; DOI: 10.3109/03639049109057315.10.3109/03639049109057315]Search in Google Scholar
[J. K. Patel, R. Patel, A. F. Amin and M. Patel, Formulation and evaluation of mucoadhesive glipizide microspheres, AAPS PharmSciTech. 6 (2005) 49-55; DOI: 10.1208/pt060110.10.1208/pt060110]Search in Google Scholar
[R. Foster and G. Plosker, Glipizide: A review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus, Pharmacoeconomics 18 (2000) 289-306.]Search in Google Scholar
[A. G. Thombre, A. R. Denoto and D. C. Gibbes, Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients, J. Control. Release 60 (1999) 333-341; DOI: 10.1023/A:1011945625750.]Search in Google Scholar
[S. Garg, K. Vermani, A. Garg, R. A. Anderson, B. W. Rencher and L. J. D. Zaneveld, Development and characterization of bioadhesive vaginal films of sodium polystyrene sufonate (PSS), a novel contraceptive antimicrobial agent, Pharm. Res. 22 (2005) 584-595.10.1007/s11095-005-2490-1]Search in Google Scholar
[R. C. Mashru, V. B. Sutariya, M. G. Sankalia and P. P. Parikh, Development and evaluation of fast-dissolving film of salbutamol sulphate, Drug Dev. Ind. Pharm. 1 (2005) 25-34; DOI: 10.3109/03612489109057315.]Search in Google Scholar
[M. A. Alam, F. J. Ahmad, Z. I. Khan, R. K. Khar and M. Ali, Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections, AAPS PharmSciTech. 8 (2007) E 1-8; DOI: 10.1208/pt0804109.10.1208/pt0804109]Search in Google Scholar
[The United States Pharmacopeia/The National Formulary, 24th ed., USA Convention, Inc., Rockville 1999, pp. 2076-2078.]Search in Google Scholar
[A. Dokoumetzidis, V. Papadopoulou, P. Macheras, Analysis of dissolution dara using modified versions of Noyes-Whitney equation and the Weibull function, Pharm. Res. 23 (2006) 256-261.]Search in Google Scholar
[R. Korsemeyer, R. Gurny and N. Peppas, Mechanisms of solute release from porous hydrophylic polymers, Int. J. Pharm. 15 (1983) 25-35.10.1016/0378-5173(83)90064-9]Search in Google Scholar
[C. R. Kahn, Y. Shechter, W. R. Theodore, S. N. Alan, P. Taylor and A. G. Gilman (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed., McGraw-Hill, New York 1991, p. 1712.]Search in Google Scholar
[M. Berelowitz, C. Fischette, W. Cefelu and D. S. Schade, Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM, Diabetes Care 17 (1994) 1460-1464.10.2337/diacare.17.12.14607882817]Search in Google Scholar